Provided by Tiger Trade Technology Pte. Ltd.

SciSparc Ltd.

5.86
+0.18503.26%
Volume:46.14K
Turnover:257.02K
Market Cap:3.40M
PE:-0.06
High:6.00
Open:5.80
Low:5.41
Close:5.67
52wk High:80.10
52wk Low:2.98
Shares:581.00K
Float Shares:561.10K
Volume Ratio:1.09
T/O Rate:8.22%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-98.0714
EPS(LYR):-98.0714
ROE:-178.39%
ROA:-60.68%
PB:0.80
PE(LYR):-0.06

Loading ...

SciSparc Subsidiary NeuroThera Labs Validates Quantum Sampling Workflow for Clinical Trials Analytics Platform

Reuters
·
Jul 29

Scisparc Announces Decision to Target the Agentic AI Market; Forms Scientific Advisory Board for Artificial Intelligence and Cybersecurity

THOMSON REUTERS
·
Jul 27

Scisparc - in Discussions with Companies in Agentic AI Field

THOMSON REUTERS
·
Jul 27

SciSparc initiates SCI-110 clinical trial in Germany

TIPRANKS
·
Jul 15

Scisparc: Neurothera Labs Announces Initiation of Phase Iib Clinical Trial at Hannover Medical School in Germany for Innovative Treatment of Tourette Syndrome

THOMSON REUTERS
·
Jul 15

Scisparc Unit Neurothera Labs Starts Phase Iib Tourette Trial Site at Hannover Medical School

Reuters
·
Jul 15

Neurothera Labs Targets up to C$ 5 Million in Private Placement of Units at C$ 0.135 Each

Reuters
·
Jul 01

SciSparc unit NeuroThera closes purchase of 54% stake in CliniQuantum for CAD 9.46 million in shares

Reuters
·
Jun 04

Scisparc: Subsidiary Neurothera Labs Completed Acquisition of Cliniquantum

THOMSON REUTERS
·
Jun 04

SciSparc director Itschak Shrem sells 462 shares for $4,620

Reuters
·
Jun 03

BUZZ-U.S. STOCKS ON THE MOVE-Snowflake, Best Buy, Kohl's

Reuters
·
May 29

Why Is SciSparc Stock Skyrocketing On Thursday?

Benzinga
·
May 29

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:30 AM

Reuters
·
May 28

SciSparc unit NeuroThera wins conditional TSX approval for CliniQuantum acquisition update

Reuters
·
May 28

Scisparc: Subsidiary Neurothera Labs Received Conditional Regulatory Approval for Acquisition of Cliniquantum

THOMSON REUTERS
·
May 28

SciSparc regains Nasdaq equity compliance, avoids delisting for now

Reuters
·
May 11

Scisparc FY25 net loss widens 94% to USD 12.18 million

Reuters
·
Apr 30

Scisparc Director Alon Dayan Files Initial Beneficial Ownership Statement

Reuters
·
Mar 24

SciSparc Ltd. CEO and CFO Oz Adler Files Initial Beneficial Ownership Statement

Reuters
·
Mar 19

Scisparc Ltd. Director Moshe Revach Files Initial Beneficial Ownership Statement

Reuters
·
Mar 19